$33.610
+0.091 (+0.27%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BOW Prediction & Forecast by Similar Chart Analysis
Alphio's BOW stock price prediction model matches the current Bowhead Specialty Holdings Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $33.40 (-0.61%). The 1-week path is $32.65 (-2.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Bowhead Specialty Holdings Inc. Stock?
Bowhead Specialty Holdings Inc is a good buy right now, trading at $33.60 with a forward P/E of 16.16, indicating it is reasonably valued for future earnings growth. The company reported a strong Q2 with a net income of $16.1 million and a significant revenue growth of 28.2% in gross written premiums, which reflects its solid market position. However, the main risk is the recent acquisition by American Family Mutual Insurance, which could impact share price volatility as the deal approaches its closing date.
BOW stock price ended at $33.61 on Tuesday, after rising +0.27%
Bowhead Specialty Holdings Inc. (BOW) last closed at $33.61, gaining +0.27%. These facts feed the 1-day and 1-week BOW price prediction above.
Forecast Drivers
Bowhead Specialty Holdings Inc. (BOW) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches BOW, ranked by similarity.
Seasonality analysis for BOW
Historically the probability of a positive September return for BOW is 50.00%. June offers the highest probability of a positive month at 80.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.